News

Cell-free DNA could detect adverse events from immunotherapy

Valvular heart disease is common in cancer patients but interventions improve survival

New gene-mapping method unlocks hidden drivers of cancer

Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia

Study reveals how dietary restriction helps fuel cancer-fighting immune cells

ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma

ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

Study reveals online support lacking for sarcoma patients and their carers

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

Enhancing breast cancer screening could help save young women’s lives